Literature DB >> 25473170

Effect of liver regeneration on malignant hepatic tumors.

Ji-Hua Shi1, Pål-Dag Line1.   

Abstract

Liver regeneration after major surgery may activate occult micrometastases and facilitate tumor growth, leading to liver tumor recurrence. Molecular changes during liver regeneration can provide a microenvironment that stimulates intrahepatic tumor propagation through alterations in cellular signaling pathways, where activation and proliferation of mature hepatocytes, hepatic progenitor cells, non-parenchymal liver cells might favor both liver regeneration and tumor growth. This review highlights recent advances of tumor growth and development in the regenerating liver, possible mechanisms and clinical implications.

Entities:  

Keywords:  Colorectal cancer; Epithelial to mesenchymal transition; Hepatic progenitor cell; Hepatocellular carcinoma; Liver regeneration; Recurrence

Mesh:

Year:  2014        PMID: 25473170      PMCID: PMC4239504          DOI: 10.3748/wjg.v20.i43.16167

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  118 in total

1.  Surgical resection for recurrent hepatocellular carcinoma: prognosis and analysis of risk factors.

Authors:  R H Hu; P H Lee; S C Yu; H C Dai; J C Sheu; M Y Lai; H C Hsu; D S Chen
Journal:  Surgery       Date:  1996-07       Impact factor: 3.982

2.  [Imaging diagnosis of hepatocellular carcinoma].

Authors:  Fu-hua Yan
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2005-02-02

3.  Clinical management of recurrent hepatocellular carcinoma.

Authors:  P H Lee; W J Lin; Y M Tsang; R H Hu; J C Sheu; M Y Lai; H C Hsu; W May; C S Lee
Journal:  Ann Surg       Date:  1995-11       Impact factor: 12.969

4.  Nitric oxide and prostaglandins potentiate the liver regeneration cascade.

Authors:  Jodi M Schoen Smith; W Wayne Lautt
Journal:  Can J Gastroenterol       Date:  2006-05       Impact factor: 3.522

5.  Clonal origin of recurrent hepatocellular carcinomas.

Authors:  P J Chen; D S Chen; M Y Lai; M H Chang; G T Huang; P M Yang; J C Sheu; S C Lee; H C Hsu; J L Sung
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

Review 6.  Current management strategy of hepatocellular carcinoma.

Authors:  Bernardino Rampone; Beniamino Schiavone; Antonio Martino; Carmine Viviano; Giuseppe Confuorto
Journal:  World J Gastroenterol       Date:  2009-07-14       Impact factor: 5.742

Review 7.  Repeated liver resection for recurrent liver cancer.

Authors:  N Neeleman; R Andersson
Journal:  Br J Surg       Date:  1996-07       Impact factor: 6.939

8.  Recruitment of host progenitor cells in rat liver transplants.

Authors:  Zhaoli Sun; Xiuying Zhang; Jayme E Locke; Qizhi Zheng; Shingo Tachibana; Anna Mae Diehl; George Melville Williams
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

9.  Function of oval cells in hepatocellular carcinoma in rats.

Authors:  Chi-Hua Fang; Jia-Qing Gong; Wei Zhang
Journal:  World J Gastroenterol       Date:  2004-09-01       Impact factor: 5.742

10.  Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathways.

Authors:  Kwan Man; Kevin T Ng; Chung Mau Lo; Joanna W Ho; Bai Shun Sun; Chris K Sun; Terence K Lee; Ronnie T P Poon; Sheung Tat Fan
Journal:  Liver Transpl       Date:  2007-12       Impact factor: 5.799

View more
  22 in total

1.  Inflammation is king in liver resection for hepatocellular carcinoma.

Authors:  Xavier Muller; Kayvan Mohkam; Jean-Yves Mabrut
Journal:  Hepatobiliary Surg Nutr       Date:  2021-12       Impact factor: 7.293

2.  Impact of the Pringle manoeuvre on the mitochondrial redox state of hepatocytes in colorectal cancer patients with liver metastases.

Authors:  Anton Burlaka; Ariadna Paliichuk; Dmytro Makhmudov; Andrii Lukashenko
Journal:  Contemp Oncol (Pozn)       Date:  2021-10-14

3.  Impact of operative and peri-operative factors on the long-term prognosis of primary liver cancer patients undergoing hepatectomy.

Authors:  Li-Ning Xu; Ying-Ying Xu; De-Wei Gao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-28

4.  Clinical outcomes of patients with a high alpha-fetoprotein level but without evident recurrence on CT or MRI in surveillance after curative-intent treatment for hepatocellular carcinoma.

Authors:  Jihyuk Lee; Ijin Joo; Dong Ho Lee; Sun Kyung Jeon; Jeong Min Lee
Journal:  Abdom Radiol (NY)       Date:  2020-08-18

Review 5.  Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment.

Authors:  Alessandro Granito; Luigi Muratori; Claudine Lalanne; Chiara Quarneti; Silvia Ferri; Marcello Guidi; Marco Lenzi; Paolo Muratori
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

6.  TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.

Authors:  Aitor Esparza-Baquer; Ibone Labiano; Omar Sharif; Aloña Agirre-Lizaso; Fiona Oakley; Pedro M Rodrigues; Ekaterina Zhuravleva; Colm J O'Rourke; Elizabeth Hijona; Raul Jimenez-Agüero; Ioana Riaño; Ana Landa; Adelaida La Casta; Marco Y W Zaki; Patricia Munoz-Garrido; Mikel Azkargorta; Felix Elortza; Andrea Vogel; Gernot Schabbauer; Patricia Aspichueta; Jesper B Andersen; Sylvia Knapp; Derek A Mann; Luis Bujanda; Jesus Maria Banales; Maria Jesus Perugorria
Journal:  Gut       Date:  2020-09-09       Impact factor: 23.059

7.  CyberKnife Radiosurgery - Value as an Adjunct to Surgical Treatment of HCC?

Authors:  Markus Schoenberg; Andrey Khandoga; Sebastian Stintzing; Christoph Trumm; Tobias Simon Schiergens; Martin Angele; Mark Op den Winkel; Jens Werner; Alexander Muacevic; Markus Rentsch
Journal:  Cureus       Date:  2016-04-28

8.  Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.

Authors:  Inger Marie Løes; Heike Immervoll; Halfdan Sorbye; Jon-Helge Angelsen; Arild Horn; Stian Knappskog; Per Eystein Lønning
Journal:  Int J Cancer       Date:  2016-04-04       Impact factor: 7.396

9.  Gene expression of NOX family members and their clinical significance in hepatocellular carcinoma.

Authors:  Hyuk Soo Eun; Sang Yeon Cho; Jong Seok Joo; Sun Hyung Kang; Hee Seok Moon; Eaum Seok Lee; Seok Hyun Kim; Byung Seok Lee
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

10.  Specific patterns of PIWI-interacting small noncoding RNA expression in dysplastic liver nodules and hepatocellular carcinoma.

Authors:  Francesca Rizzo; Antonio Rinaldi; Giovanna Marchese; Elena Coviello; Assunta Sellitto; Angela Cordella; Giorgio Giurato; Giovanni Nassa; Maria Ravo; Roberta Tarallo; Luciano Milanesi; Anna Destro; Guido Torzilli; Massimo Roncalli; Luca Di Tommaso; Alessandro Weisz
Journal:  Oncotarget       Date:  2016-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.